相似文献
1
Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery.
Gene Ther. 2007 Apr;14(8):682-9. doi: 10.1038/sj.gt.3302910. Epub 2007 Feb 1.
2
Octaarginine-modified multifunctional envelope-type nano device for siRNA.
J Control Release. 2007 Jun 22;119(3):360-7. doi: 10.1016/j.jconrel.2007.03.010. Epub 2007 Mar 23.
3
[Development of various multifunctional envelope-type nano device MEND based on novel assembly technologies].
Yakugaku Zasshi. 2008 Feb;128(2):219-32. doi: 10.1248/yakushi.128.219.
4
[Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
Yakugaku Zasshi. 2007 Oct;127(10):1685-91. doi: 10.1248/yakushi.127.1685.
5
Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
J Control Release. 2009 Sep 1;138(2):160-7. doi: 10.1016/j.jconrel.2009.05.018. Epub 2009 May 21.
6
A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.
Int J Pharm. 2005 Sep 14;301(1-2):277-85. doi: 10.1016/j.ijpharm.2005.05.021.
7
Comparison between a multifunctional envelope-type nano device and lipoplex for delivery to the liver.
Biol Pharm Bull. 2010;33(5):926-9. doi: 10.1248/bpb.33.926.
8
A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Acc Chem Res. 2012 Jul 17;45(7):1113-21. doi: 10.1021/ar200254s. Epub 2012 Feb 10.
9
Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Biomaterials. 2015 Jun;52:189-98. doi: 10.1016/j.biomaterials.2015.02.027. Epub 2015 Feb 25.
10
Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
J Control Release. 2011 Dec 20;156(3):374-80. doi: 10.1016/j.jconrel.2011.08.012. Epub 2011 Aug 12.
引用本文的文献
1
Topical Application of RNAi Therapy Using Surface-Modified Liposomes for Treating Retinal-Vein Occlusion.
Molecules. 2025 Jun 17;30(12):2622. doi: 10.3390/molecules30122622.
2
Development of Liposomes That Target Axon Terminals Encapsulating Berberine in Cultured Primary Neurons.
Pharmaceutics. 2023 Dec 28;16(1):49. doi: 10.3390/pharmaceutics16010049.
3
Looking Back, Moving Forward: Lipid Nanoparticles as a Promising Frontier in Gene Delivery.
ACS Pharmacol Transl Sci. 2023 Oct 24;6(11):1561-1573. doi: 10.1021/acsptsci.3c00185. eCollection 2023 Nov 10.
4
A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles.
J Nanobiotechnology. 2023 Oct 10;21(1):370. doi: 10.1186/s12951-023-02139-z.
5
A Comparison of Cellular Uptake Mechanisms, Delivery Efficacy, and Intracellular Fate between Liposomes and Extracellular Vesicles.
Adv Healthc Mater. 2023 Oct;12(25):e2300319. doi: 10.1002/adhm.202300319. Epub 2023 Jul 9.
6
Delivery Systems for Mitochondrial Gene Therapy: A Review.
Pharmaceutics. 2023 Feb 8;15(2):572. doi: 10.3390/pharmaceutics15020572.
7
Comparison of two methods for tumour-targeting peptide modification of liposomes.
Acta Pharmacol Sin. 2023 Apr;44(4):832-840. doi: 10.1038/s41401-022-01011-4. Epub 2022 Oct 21.
8
A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide.
RSC Adv. 2021 Nov 10;11(57):36116-36124. doi: 10.1039/d1ra05871a. eCollection 2021 Nov 4.
9
Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.
Biochemistry. 2021 Apr 6;60(13):966-990. doi: 10.1021/acs.biochem.0c00860. Epub 2021 Jan 11.
10
Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Acta Pharm Sin B. 2020 Nov;10(11):2075-2109. doi: 10.1016/j.apsb.2020.10.005. Epub 2020 Oct 13.
本文引用的文献
1
Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery.
Pharmacol Rev. 2006 Mar;58(1):32-45. doi: 10.1124/pr.58.1.8.
2
Intranuclear disposition of exogenous DNA in vivo: silencing, methylation and fragmentation.
FEBS Lett. 2006 Feb 6;580(3):918-22. doi: 10.1016/j.febslet.2006.01.017. Epub 2006 Jan 19.
3
Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems.
Mol Ther. 2006 Apr;13(4):786-94. doi: 10.1016/j.ymthe.2005.10.007. Epub 2005 Dec 20.
4
High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.
J Biol Chem. 2006 Feb 10;281(6):3544-51. doi: 10.1074/jbc.M503202200. Epub 2005 Dec 2.
5
A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.
Int J Pharm. 2005 Sep 14;301(1-2):277-85. doi: 10.1016/j.ijpharm.2005.05.021.
6
Convective flow increases lipoplex delivery rate to in vitro cellular monolayers.
Gene Ther. 2005 Mar;12(6):512-20. doi: 10.1038/sj.gt.3302397.
7
Cationic TAT peptide transduction domain enters cells by macropinocytosis.
J Control Release. 2005 Jan 20;102(1):247-53. doi: 10.1016/j.jconrel.2004.10.018.
8
Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement.
Mol Ther. 2004 Dec;10(6):1011-22. doi: 10.1016/j.ymthe.2004.08.010.
9
Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.
J Control Release. 2004 Aug 11;98(2):317-23. doi: 10.1016/j.jconrel.2004.04.024.
10
Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Biochemistry. 2004 May 18;43(19):5618-28. doi: 10.1021/bi035802w.
Zotero 插件